Key Findings

The company confirms that there are no deviations or variations in respect of the utilization of proceeds from the Preferential Issue of the Company during the quarter ended June 30, 2026. The fund utilization remains consistent with the objects approved by shareholders in the Annual General Meeting held on September 28, 2025.

Fund Raising and Utilization Details

Preferential Issue Structure

  • Instrument: Equity Convertible Warrants
  • Total Warrants Allotted: 25,00,000 warrants
  • Allotment Date: January 12, 2026
  • Allottees: Promoters, Promoters Group, and Non-promoters

Fund Receipts

  • Initial Amount Received (25% of issue price): ₹1,25,00,000
  • Received on warrant allotment (January 12, 2026)
  • Additional Amount Received (75% upon conversion): ₹90,00,000
  • Received upon conversion of 6,00,000 warrants to equity shares during Q2 2026

Equity Share Conversion

  • Equity Shares Allotted: 6,00,000 shares
  • Conversion Date: June 25, 2026
  • Total Funds Raised through Conversion: ₹90,00,000

Fund Utilization (as of June 30, 2026)

  • Total Funds Utilized from Warrant Proceeds: ₹1,25,00,000
  • Total Funds Utilized from Conversion Proceeds: ₹50,00,000
  • Cumulative Utilization: ₹1,75,00,000

Original Objects of Fund Raising

The funds were raised for the following purposes as approved by shareholders:

  • To meet funding and business requirements
  • Business growth financing
  • Capital expenditure
  • Expansion plans
  • Diversification of business model
  • Working capital requirements
  • General corporate purposes

Monitoring

  • Monitoring Agency: Not Applicable (NA)

#Tags: #FruitionVenture #SEBIReg32 #FundUtilization #ComplianceDisclosure #Neutral